bosentan anhydrous has been researched along with Syncope in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aizawa, Y; Ito, E; Maie, K; Ohno, Y; Sato, A; Tanabe, Y; Yoshida, T | 1 |
Caballero Eraso, C; Elías Hernández, T; Ferrer Galván, M; Jara Palomares, L; López Villalobos, JL; Otero Candelera, R | 1 |
Abe, H; Otsuji, Y; Suzuki, Y; Tamura, M; Tanaka, S; Tasaki, H; Yamanaka, A; Yamashita, K | 1 |
3 other study(ies) available for bosentan anhydrous and Syncope
Article | Year |
---|---|
Efficacy and safety of bosentan treatment for portopulmonary hypertension associated with syncope.
Topics: Adult; Antihypertensive Agents; Bosentan; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Hypertension, Portal; Hypertension, Pulmonary; Male; Monitoring, Physiologic; Pulmonary Wedge Pressure; Sulfonamides; Syncope | 2011 |
Chronic thromboembolic pulmonary hypertension due to upper-extremity deep vein thrombosis caused by thoracic outlet syndrome.
Topics: Antihypertensive Agents; Arm; Asthma; Bosentan; Cardiac Catheterization; Dyspnea; Female; Humans; Hypertension, Pulmonary; Pulmonary Embolism; Smoking; Sulfonamides; Syncope; Thoracic Outlet Syndrome; Thrombophlebitis; Young Adult | 2012 |
Bosentan improved syncope in a hemodialysis patient with pulmonary hypertension and mild aortic stenosis.
Topics: Aged; Antihypertensive Agents; Aortic Valve Stenosis; Bosentan; Female; Humans; Hypertension, Pulmonary; Renal Dialysis; Sulfonamides; Syncope | 2006 |